Zepbound vs Wegovy: which works better and which is easier to get online?

Short answer

• On average, Zepbound (tirzepatide) has produced larger weight‑loss results in clinical trials than Wegovy (semaglutide).
• Wegovy is usually easier to obtain online today because it’s been on the market longer and more telehealth clinics and programs prescribe semaglutide for weight management. However both require a prescription and medical evaluation.

Key differences that matter

• Mechanism: Zepbound = tirzepatide (dual GIP + GLP‑1 receptor agonist). Wegovy = semaglutide (GLP‑1 receptor agonist). The additional GIP activity in tirzepatide appears to boost weight‑loss effectiveness for many people.
• Efficacy: In clinical studies tirzepatide produced larger average percent weight loss than semaglutide. Individual responses vary, though, and not everyone will get the same benefit.
• Dosing: Both are once‑weekly injectable medications with gradual dose titration to reduce GI side effects. Zepbound is available in multiple incremental doses; Wegovy titrates up to 2.4 mg.
• Side effects: Both commonly cause gastrointestinal effects (nausea, vomiting, diarrhea, constipation). Some data suggest tirzepatide may cause somewhat more GI effects at higher doses, but tolerability is individual.
• Safety considerations: Both have similar warnings (e.g., possible pancreatitis, gallbladder issues, and a boxed warning re: rodent thyroid C‑cell tumors). Neither should be used in pregnancy. Discuss personal/ family thyroid cancer history and other conditions with a clinician.

Which is easier to get online

• Wegovy (semaglutide) is generally easier to get via telehealth or online weight‑loss programs because it’s more established for obesity, and more clinics are set up to prescribe it. That said, there have been supply and insurance/authorization issues from time to time.
• Zepbound (tirzepatide) is newer for obesity and may be harder to obtain through some online clinics; some prescribers will prioritize in‑person evaluation or require prior authorization. Availability will vary by clinic and geography.

Where to look online (examples)

• Telehealth clinics that commonly offer GLP‑1 weight‑loss care include Hims & Hers, Ro (Rory), PlushCare, and some specialty weight‑management providers (e.g., SteadyMD, Parsley Health). Availability of Wegovy vs Zepbound differs by provider.
• Check manufacturers’ patient support programs too: Novo Nordisk (Wegovy) and Eli Lilly (Zepbound) have resources and sometimes savings programs that can help with access.

What I recommend

1. Talk with your primary care doctor or an endocrinologist first—medical history, pregnancy plans, thyroid/family history, and labs matter.
2. If you prefer easier/ faster online access, start by checking telehealth weight‑loss clinics (ask specifically whether they prescribe Wegovy vs Zepbound).
3. If maximum average weight loss is your top priority and you’re willing to navigate prior authorizations or specialty prescribing, ask about tirzepatide (Zepbound).
4. Compare cost and insurance coverage—both can be expensive without coverage. Ask about manufacturer savings programs.

If you want, I can:

• Scan a few specific telehealth providers for current availability of Wegovy vs Zepbound in your state (tell me your state), or
• Draft questions to send to your clinician or an online clinic (insurance/coverage, contraindications, monitoring).